Abstract
The aim of this study is to evaluate the effects of intrapolyp, systemic and local corticosteroid treatment modalities on MMP-9 and TIMP-1 level in polyp tissues. This study included 71 patients and five groups. Group A treated with oral methylprednisolone, Group B, treated with topical steroid spray, Group C treated with intralesional triamcinolone acetonide, Group D patients with nasal polyposis who has not given any medication, Group E had surgery for concha bullosa without nasal polyp disease. Samples from group A were collected endoscopically 1 day after treatment was stopped. Group B samples were collected at the end of the first month. Video guided sample collection from Group C was also performed on the 7th day after treatment. MMP-9 and TIMP-1 levels were measured by Enzyme-linked immunosorbent assay method. When we compared the MMP-9 levels of all groups, there were no significant differences. There was significant difference of TIMP-1 level between Groups C and E (pC–E = 0.0019), however there was no difference among the level of the other groups. When MMP-9/TIMP1 rates of all groups were compared, there were significant difference between Group A and D (pA–D = 0.005) and between Group A and E, also between Group C and E. Our study is the first study to evaluate the effects of different corticosteroid treatment modalities on MMP-9 and TIMP-1 in nasal polyps and concluded that corticosteroid did not do a significant impact on this pathway.
Similar content being viewed by others
References
Tos M, Larsen PL (2001) Nasal polyposis: origin, etiology, pathogenesis and structure. In: Kennedy DW, Bolger WE, Zinreich SJ (eds) Diseases of the sinuses: current therapy and management. B. C. Decker, Philadelphia, pp 57–68
Can IH, Ceylan K, Caydere M, Samim EE, Ustun H, Karasoy DS (2008) The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg 139(2):211–215
Nagase H, Woessner JF Jr (1999) Matrix metalloproteinases. J Biol Chem 274:21491–21494
Watelet JB, Bachert C, Claeys C, Van Cauwenberge P (2004) Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs. nasal polyposis. Allergy 59:54–60
Lechapt-Zalcman E, Coste A, d’Ortho MP et al (2001) Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193:233–241
Kostamoa K, Toskalab E, Tervahartiala T, Sorsa T (2008) Role of matrix metalloproteinases in chronic rhinosinusitis. Curr Opin Allergy Clin Immunol 8:21–27
Kahveci OK, Derekoya FS, Yılmaz MD, Serteser M, Altuntas A (2008) The role of MMP-9 and TIMP-1 in nasal polyp formation. Swiss Med Wkly 138(45–46):684–688
Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477:267–283
Liu CM, Hong CY, Shun CT et al (2001) Matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expressions and their differential regulation by proinflammatory cytokines and prostaglandin in nasal polyp fibroblasts. Ann Otol Rhinol Laryngol 110:1129–1136
Yigit O, Acioglu E, Gelisgen R, Server EA, Azizli E, Uzun H (2011) The effect of corticosteroid on metalloproteinase levels of nasal polyposis. Laryngoscope 121:667–673
Bachert C, Watelet JB, Gevaert P, Van Cauwenberge P (2005) Pharmacological management of nasal polyposis. Drugs 65(11):1537–1552
Kylmaniemi M, Oikarinen A, Oikarinen K, Salo T (1996) Effects of dexamethasone and cell proliferation on the expression of matrix metalloproteinases in human mucosal normal and malignant cells. J Dent Res 75:919–926
Tanaka H, Miyazaki N, Oashi K, Tanaka S, Ohmichi M, Abe S (2000) Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J Allergy Clin Immunol 105:900–905
Drake-Lee A (1997) The pathogenesis of nasal polyps. In: Settipane GA, Lund VJ, Bernstein JM, Tos M (eds) Nasal polyps: epidemiology, pathogenesis and treatment. Ocean-Side Publications Inc, Rhode Islands, pp 57–64
DeMarcantonio MA, Han JK (2011) Nasal polyps: pathogenesis and treatment implications. Otolaryngol Clin North Am 44:685–695
De S, Fenton JE, Jones AS (2005) Matrix metalloproteinases and their inhibitors in nonneoplastic otorhinolaryngological disease. J Laryngol Otol 119:436–442
Pawankar R, Watanabe S, Nonaka M, Ozu C, Aida M, Yagi T (2004) Differential expression of matrix metalloproteinase 2 and 9 in the allergic nasal mucosa and nasal polyps. J Allergy Clin Immunol 113:1229 (abstract)
Chen YS, Langhammer T, Westhofen M, Lorenzen J (2007) Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL- in nasal polyps. Allergy 62:66–72
Lee YM, Kim SS, Kim HA et al (2003) Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1. J Korean Med Sci 18:97–102
Toi M, Ishigaki S, Tominaga T (1998) Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat 52:113–124
Yuan Y, Wang Z, Dong B (2003) Modulation of matrix metalloproteinase by dexamethasone in airway remodeling in asthmatic rats. Sichuan Da Xue Xue Bao Yi Xue Ban 34:680–683
Hoshino M, Takahashi M, Takai Y, Sim J, Aoike N (1999) Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 104:356–363
Obase Y, Rytilä P, Metso T et al (2010) Effects of inhaled corticosteroids on metalloproteinase-8 and tissue inhibitor of metalloproteinase-1 in the airways of asthmatic children. Int Arch Allergy Immunol 151(3):247–254
Acknowledgments
Authors wish to thank Özlem Köksal for statistical analysis of data, and epidemiological committee and its chief Mustafa Gultepe Prof. for scientific support.
Conflict of interest
No conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cincik, H., Erkul, E., Pinar, D. et al. Evaluation of MMP-9 and TIMP-1 Levels of the Patients with Nasal Polyposis After Corticosteroid Therapies. Indian J Otolaryngol Head Neck Surg 65 (Suppl 2), 445–449 (2013). https://doi.org/10.1007/s12070-013-0656-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12070-013-0656-4